Form D · Other Health Care
ENDOTRONIX INC
Lisle, IL · CIK 0001424668
Offering snapshot reported Dec 7, 2020 · SEC filing
- Reported sold
- $69.3M Offering amount: $90.8M
- Investors reported
- 38 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 14, 2018 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$55,382,667 → $69,277,224
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2020 | Amendment | $69,277,224 | $13,894,557vs Oct 16, 2019 | 38 | SEC filing |
| Oct 16, 2019 | Amendment | $55,382,667 | $35,132,498vs Sep 28, 2018 | 38 | SEC filing |
| Sep 28, 2018 | Initial | $20,250,169 | No comparison | 31 | SEC filing |
| Feb 26, 2018 | Amendment | $37,100,866 | $18,149,616vs Jul 19, 2016 | 52 | SEC filing |
| Jul 19, 2016 | Initial | $18,951,250 | No comparison | 51 | SEC filing |
| Dec 31, 2015 | Amendment | $2,960,000 | $2,460,000vs Jul 1, 2015 | 25 | SEC filing |
| Jul 1, 2015 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Feb 13, 2015 | Amendment | $2,197,273 | $2,097,680vs Sep 12, 2014 | 10 | SEC filing |
| Sep 12, 2014 | Initial | $99,593 | No comparison | 3 | SEC filing |
| Apr 29, 2014 | Initial | $1,600,000 | No comparison | 4 | SEC filing |
| Jun 13, 2013 | Initial | $1,193,200 | No comparison | 13 | SEC filing |
| Aug 27, 2012 | Amendment | $1,795,000 | $1,055,000vs Aug 9, 2011 | 14 | SEC filing |
| Aug 9, 2011 | Initial | $740,000 | No comparison | 8 | SEC filing |
| Feb 17, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 17, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-322392
Source: Form D, filed Dec 7, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Fouad Azzam | Director |
| Raymond S. Barrett, Jr. | Director |
| Gerry Brunk | Director |
| Kent Elmer | Executive |
| John Flavin | Executive |
| Marc Goldberg | Director |
| James Hummer | Director |
| Jonathan Jonas | Director |
| Paul La Violette | Director |
| Sam R. Leno | Director |
| Jennifer Mc Mahon | Director |
| Anthony Nunez | Executive |
| Reed Prior | Executive |
| Harry Rowland | Director, Executive |
| Leslie Saxon | Director |
| Colleen Victory | Director |
| Robert Zieserl | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
815 Ogden Avenue
Lisle, IL, 60532
Lisle, IL, 60532